Meeting Banner
Abstract #0687

Initial Experience of Hyperpolarized 13C Pyruvate MRI in Patients with Renal Tumors

Shuyu Tang1, Peder E.Z. Larson1, Maxwell Meng1, James Slater1, Jeremy Gordon1, Daniel B. Vigneron1, and Zhen J. Wang1
1University of California, San Francisco, San Francisco, CA, United States

We present our initial experience of applying HP 13C pyruvate MRI in patients with renal tumors. Distinct tumor metabolic pattern and heterogeneity can be observed on HP 13C pyruvate MRI. Our data from subjects with two injections also suggests that the metabolite measurements are reproducible. This initial experience paves the way for this metabolic imaging technique to be applied for differentiating between benign renal tumors, low grade RCCs and high grade RCCs.

This abstract and the presentation materials are available to 2020 meeting attendees and eLibrary customers only; a login is required.

Join Here